These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 206058)
1. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia]. Weisweiler P; Schwandt P Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():398-401. PubMed ID: 206058 [No Abstract] [Full Text] [Related]
2. Clofibrate and related compounds in hyperlipoproteinaemia. A review. Gustafson A Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983 [No Abstract] [Full Text] [Related]
3. [Familial hyperlipoproteinemia type III]. Patsch JR; Patsch W; Sailer S; Braunsteiner H Dtsch Med Wochenschr; 1976 Oct; 101(44):1612-9. PubMed ID: 185039 [No Abstract] [Full Text] [Related]
4. A double-blind comparison of the hypolipidemic and hypouricemic action of halofenate and clofibrate in patients with hyperlipoproteinemia (types III, IV and V). Neuman J; de Neuman MP; Talmasky S; Pesce R; Valero E; Martiarena JL J Cardiovasc Surg (Torino); 1973; Spec No():532-7. PubMed ID: 4377715 [No Abstract] [Full Text] [Related]
5. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V]. Hutt V; Wechsler JG; Klör HU; Ditschuneit H Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558 [TBL] [Abstract][Full Text] [Related]
6. Treatment of hyperlipidemia. Levy RI; Morganroth J; Rifkind BM N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888 [No Abstract] [Full Text] [Related]
7. A physician's guide to hyperlipidemia. Fredrickson DS Mod Concepts Cardiovasc Dis; 1972 Jul; 41(7):31-6. PubMed ID: 4343098 [No Abstract] [Full Text] [Related]
9. Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia. Miettinen TA; Penttilä IM; Lampainen E Acta Med Scand; 1972 Sep; 192(3):177-82. PubMed ID: 4341290 [No Abstract] [Full Text] [Related]
10. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia. Patsch JR; Yeshurun D; Jackson RL; Gotto AM Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188 [No Abstract] [Full Text] [Related]
11. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)]. Weisweiler P; Schwandt P Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601 [TBL] [Abstract][Full Text] [Related]
12. [Clofibrate treatment of diabetics with hyperproteinemias (author's transl)]. Jung W; Kremer GJ; Müller D MMW Munch Med Wochenschr; 1975 Oct; 117(44):1783-6. PubMed ID: 171564 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate]. Gaertner U; Johannes KJ MMW Munch Med Wochenschr; 1976 Sep; 118(36):1127-30. PubMed ID: 184377 [TBL] [Abstract][Full Text] [Related]
14. [The problem of type changes in hyperlipoproteinemia (type IIb, IV, V) under clofibrate and m-inositol nicotinate therapy]. Schwartzkopff W; Zschiedrich M Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():825-9. PubMed ID: 196436 [No Abstract] [Full Text] [Related]
15. Dietary and drug treatment of primary hyperlipoproteinemia. Ann Intern Med; 1972 Aug; 77(2):267-94. PubMed ID: 4345081 [No Abstract] [Full Text] [Related]
16. Secholex, Clofibrate and taurine in hyperlipidaemia. Howard AN; Evans RJ Atherosclerosis; 1974; 20(1):105-16. PubMed ID: 4376405 [No Abstract] [Full Text] [Related]
17. [Use of miskleron in ischemic heart disease with differing types of hyperlipoproteinemias]. Krivoruchenko IV; Nikul'cheva NG Kardiologiia; 1976 Jul; 16(7):71-5. PubMed ID: 185448 [TBL] [Abstract][Full Text] [Related]
18. Hyperlipoproteinemia. Some basic concepts on diagnosis and management. Levy RI JAMA; 1973 Nov; 226(6):648-9. PubMed ID: 4356846 [No Abstract] [Full Text] [Related]